Redrawing the Breast Cancer Roadmap Advancing Novel Therapies Into First-Line and Early Disease Settings EBAC ACCREDITED Friday, 23 October 2026, 09:45 - 11:15 CEST PAMPLONA AUDITORIUM, HALL 5, IFEMA MADRID, MADRID, SPAIN

https://events.medscapelive.org/website/98784/?utm_campaign=436468.01_esmo_email&utm_source=edu&utm_medium=em&utm_content=ext The breast cancer landscape is shifting rapidly as newer therapies such as next-generation oral selective estrogen receptor degraders (SERDs) and antibody-drug conjugates (ADCs) move from later lines into earlier treatment settings across the spectrum of disease. Join our distinguished panel of experts as they discuss how to use and manage this fast-changing armamentarium to maximize clinical outcomes and quality of life for individual patients